Sensorion to Initiate a Phase 2 Clinical Trial with SENS-111

Read

Sensorion receives Orphan Drug Designation in Europe for SENS-401 in Sudden Sensorineural Hearing Loss

Read

Sensorion Presents New Preclinical Results with SENS-401 at Neuroscience 2016

Read

Sensorion Obtains a Positive Opinion on Granting of Orphan Medicinal Product Designation for SENS-401 in Europe

Read

2016 first-half results

Read

Pipeline

20190603 pipeline

Enregistrer

Patient center

Corporate presentation

Next events